What is the most commonly reported complaint after the patient regains consciousness? Test your clinical acumen here.
Some recent breakthroughs, using newly developed neuroscience investigational tools, suggest that if research resources are available, we could soon make substantial advances in understanding the mechanism of action of ECT.
We have medications that can affect serotonin, norepinephrine, and—to a lesser extent—dopamine. Many other neurotransmitters are involved with mood disorders, but we have no medications yet to target them. Neurostimulation offers a non-systemic somatic approach to depression, often with an improved side effect profile. More in this Q&A.
Cranial electrotherapy devices, soon to be only home-use device approved to treat depression, can be an essential adjunctive treatment to standard modalities of care for soldiers and veterans, says this psychiatrist.
More than 50 years have passed since One Flew Over the Cuckoo’s Nest was published, and almost 40 years since the movie was released, but the issues seem as relevant today as they were back then. If you haven’t seen the film or have forgotten what you saw, see it again as soon as you can. Here's why.
The authors review the clinical use of ketamine as the anesthetic induction agent in ECT and discuss the evidence that it augments antidepressant response and reduces cognitive adverse effects.
A reexamination of flurothyl infusions holds promise for improved resolution of severe mood disorders, as well as for a greater understanding of the mechanism of their pathophysiology.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.